Sapacitabine (CS-682)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 15:03, 17 August 2018 by Jwarner (talk | contribs)
Jump to navigation Jump to search

Mechanism of action

Pyrimidine analogue

Preliminary results

Acute myeloid leukemia

  1. Kantarjian H, Faderl S, Garcia-Manero G, Luger S, Venugopal P, Maness L, Wetzler M, Coutre S, Stock W, Claxton D, Goldberg SL, Arellano M, Strickland SA, Seiter K, Schiller G, Jabbour E, Chiao J, Plunkett W. Oral sapacitabine for the treatment of acute myeloid leukaemia in elderly patients: a randomised phase 2 study. Lancet Oncol. 2012 Nov;13(11):1096-104. Epub 2012 Oct 15. link to original article link to PMC article PubMed
Retrieved from "https://hemonc.org/w/index.php?title=Sapacitabine_(CS-682)&oldid=30053"